About CRM TRIAL CONNECT 2026

The 2025 edition of CRM Trial Connect marked a defining moment for Asia’s ascent as a regional epicentre for high-quality clinical research. Gathering more than 1,000 delegates from nearly 200 organisations — spanning global research centres, hospitals, regulators, CROs and sponsors — the conference delivered not only scale, but real depth in capacity-building, regulatory advancement and collaborative energy.

In 2026, the momentum widens. CRM Trial Connect 2026 is set to deliver an even more impactful programme, bringing together thought leaders and practitioners across key domains: oncology research excellence, best-in-class clinical trial site operations, and the growing tapestry of cross-border collaboration in clinical trials.

Adding to its strength, two capability-building workshops — centred on oncology and infectious diseases — will take place ahead of the conference, supported by returning and newly-minted programme partners.

With its expanding ecosystem of collaborators and its focus on elevating research readiness across the region, CRM Trial Connect 2026 stands as a one-stop platform for accelerating Asia’s clinical research future. ✦